Skip to main content

Table 1 Clinical characteristics of study population stratified by gender (Mean ± SD)

From: Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTOvariants confer a significant risk

   T2D Cases NGT  
  Gender 532 (299M/233F)* 386 (184M/202F) pvalue**
Age (yrs) M* 53. 2 ± 11.1 51.7 ± 15.6 0.006
  F 55.2 ± 11.0 50.8 ± 13.0 0.001
Age at     
diagnosis (yrs) M 47.5 ± 10.9 -- --
  F 48.2 ± 10.5 -- --
Duration of     
Diabetes (yrs) M 8.6 ± 7.4 -- --
  F 7.3 ± 6.0 -- --
BMI M 26.6 ± 4.3 26.6 ± 4.4 0.912
  F 29.0 ± 5.5 27.5 ± 4.9 <0.001
WHR M 0.99 ± 0.06 0.97 ± 0.07 0.002
  F 0.93 ± 0.07 0.91 ± 0.07 <0.001
Fasting Glucose     
(mmol/l) M 10.1 ± 3.7 5.4 ± 0.6 <0.0001
  F 10.0 ± 3.5 5.4 ± 0.5 <0.0001
Fasting     
Insulin(IU/ml) M 9.1 ± 7.9 11.0 ± 9.2 0.057
  F 8.8 ± 7.4 11.5 ± 9.5 0.002
HbA1c (%) M 8.6 ± 2.4 5.6 ± 0.7 <0.0001
  F 8.6 ± 2.5 5.6 ± 0.7 <0.0001
  1. *M – male, F – female; Waist to hip ratio; ** Difference between T2D cases and NGT controls